Mirum Pharmaceuticals, Inc. MIRM
Set alert
87.78 USD +2.04 +2.38%
As of Nov 3, 11:51 AM ET
85.89 Day range 88.54
63.23 52-week range 130.00
- YTD
- +11.13%
- 1 year
- +23.90%
- Open
- 85.89
- Prev close
- 85.74
- Mkt cap
- 5.69B
- Vol
- 151.39K
- Avg vol
- 723.78K
- EPS
- -14.10
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 85.89
- High
- 88.54
- Forward P/E
- -121.62
- Beta
- 0.74
- Short ratio
- 7.16
- Inst. own
- 113.63%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 3, 2026
- 50-d avg
- 89.93
- 200-d avg
- 98.57
- 1y target
- 153.43
Analyst view
Consensus: strong buy
Strong buy
Price target (mean) 153.43 +74.8% upside
Now 87.78
- Target (low)
- 118.00
- Target (mean)
- 153.43
- Target (high)
- 200.00
Ratings (0m) 14 14 buy · 0 hold · 0 sell
- Strong buy4
- Buy10
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 14
- 1 month ago 14
- 2 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.415 | -0.53 – -0.30 | 0.05 | -930.0% | 178.04M | +33.9% | 2 |
| Next quarter | -0.44 | -0.44 – -0.44 | -0.12 | -266.7% | 183.22M | +23.0% | 1 |
| Current year | -15.23 | -15.23 – -15.23 | -0.47 | -3140.4% | 698.11M | +33.9% | 1 |
| Next year | -0.705 | -1.24 – -0.17 | -15.23 | +95.4% | 819.57M | +17.4% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 21, 2026 | TD Cowen | Maintained | Buy | Buy |
| Oct 15, 2026 | Stifel | Maintained | Buy | Buy |
| Oct 13, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| Oct 13, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Oct 12, 2026 | Citigroup | Maintained | Buy | Buy |
| Oct 12, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Oct 8, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Sep 29, 2026 | Citigroup | Maintained | Buy | Buy |
| Sep 29, 2026 | Baird | Maintained | Outperform | Outperform |
| Sep 28, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Aug 27, 2026 | Citizens | Reiterated | Market Outperform | Market Outperform |
| Aug 6, 2026 | TD Cowen | Maintained | Buy | Buy |
| Aug 6, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Aug 6, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Aug 6, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Jul 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| Jul 2, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jun 15, 2026 | Citizens | Maintained | Market Outperform | Market Outperform |
| Jun 11, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| Jun 2, 2026 | Citigroup | Initiated | — | Buy |
| May 19, 2026 | Wolfe Research | Initiated | — | Outperform |
| May 7, 2026 | TD Cowen | Maintained | Buy | Buy |
| May 7, 2026 | RBC Capital | Maintained | Outperform | Outperform |
| May 7, 2026 | Evercore ISI Group | Maintained | Outperform | Outperform |
| May 7, 2026 | Baird | Maintained | Outperform | Outperform |
| May 5, 2026 | Morgan Stanley | Maintained | Overweight | Overweight |
| May 4, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |
| Apr 29, 2026 | Stifel | Maintained | Buy | Buy |
| Apr 28, 2026 | Baird | Maintained | Outperform | Outperform |
| Apr 27, 2026 | HC Wainwright & Co. | Maintained | Buy | Buy |